Aerocrine: South Carolina Adopts Positive Coverage of Aerocrine’s FeNo Testing … – Business Wire (press release)

Aerocrine: South Carolina Adopts Positive Coverage of Aerocrine's FeNo Testing
Business Wire (press release)
“FeNO testing is a significant advancement in managing the patient with asthma. Since the publication of the American Thoracic Guideline on FeNO, this test should be standard of care in every clinic managing asthma patients.
South Carolina adopts positive coverage of Aerocrine's FeNO testing in CisionWire (press release)

all 2 news articles »

View full post on asthma – Google News

Drug researched at CU-Boulder licensed – Boulder County Business Report

Drug researched at CU-Boulder licensed
Boulder County Business Report
Ibudilast is part of a clinical trial that is one step required by the US Food and Drug Administration to be approved for commercial sale. It has been used in asthma and post-stroke disorders in Japan for about 20 years, according to the press
MediciNova and University of Colorado Boulder Collaborate on Potential Novel MarketWatch (press release)

all 6 news articles »

View full post on asthma – Google News

GSK, Theravance report completion of Relovair studies in COPD and asthma – Pharmaceutical Business Review


Visit Bulgaria

GSK, Theravance report completion of Relovair studies in COPD and asthma
Pharmaceutical Business Review
GlaxoSmithKline (GSK) and Theravance have announced the completion of the phase III registration programme for the once-daily investigational medicine Relovair used to treat chronic obstructive pulmonary disease (COPD) and asthma.
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies MarketWatch (press release)
Theravance Falls Most in 3 Years After Glaxo Drug FailsBusinessWeek
Glaxo on the slide after trials setback for asthma drugEvening Standard
Visit Bulgaria –TheStreet.com –Wall Street Journal (India)
all 64 news articles »

View full post on asthma – Google News

GSK to seek approval of Theravance lung drug – San Francisco Business Times (blog)

GSK to seek approval of Theravance lung drug
San Francisco Business Times (blog)
GlaxoSmithKline will seek approval of the COPD drug Relovair in the United States and Europe in mid-year, and it and partner Theravance Inc. will continue to talk to regulators about also using the drug for asthma patients.
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies MarketWatch (press release)
Glaxo set to submit Relovair to regulatory authoritiesShareCast
GSK aims to file new lung drug Relovair in mid-2012Reuters UK
Capital.gr (press release)
all 12 news articles »

View full post on asthma – Google News

Johns Hopkins wins $8.5M to study asthma among blacks – Baltimore Business Journal

Johns Hopkins wins $8.5M to study asthma among blacks
Baltimore Business Journal
Johns Hopkins Medicine researchers have won a $9.5 million federal grant to study why asthma is more common among blacks. The four-year effort will study the genetic code of 1000 people of African descent, including men and women from Baltimore.
$9.5 Million Federal Grant to Support "Asthma Genome" Project with African Newswise (press release)
Researchers look to genetics to understand African American-asthma linkBaltimore Sun (blog)

all 4 news articles »

View full post on asthma – Google News

Asthmatic Man Dies After Being Arrested for Breaking Into Car in NYC – International Business Times


International Business Times

Asthmatic Man Dies After Being Arrested for Breaking Into Car in NYC
International Business Times
By Connor Adams Sheets | December 23, 2011 4:19 PM EST An asthmatic man died Thursday shortly after being arrested while trying to break into a car in Manhattan, officials told the New York Post. A 52-year-old called 911 to report that the man was

View full post on asthma – Google News

U of L physicians first in Kentucky to offer new asthma treatment – Louisville Business First

U of L physicians first in Kentucky to offer new asthma treatment
Louisville Business First
Physicians with the pulmonary, critical care and sleep disorders medicine practice of University Medical Associates, with University of Louisville Hospital , are the first in Kentucky to offer a new asthma treatment. The Alair Bronchial Thermoplasty

View full post on asthma – Google News